France Respiratory Devices Market: Market Size & Forecast 2026

France represents one of the leading respiratory devices markets in Europe, supported by a well-established healthcare infrastructure and the Sécurité Sociale universal coverage system that reimburses a broad range of respiratory products and therapies. The market covers hospital-based critical care equipment, long-term oxygen therapy devices, positive airway pressure systems for sleep apnea, and various diagnostic and monitoring tools. With an estimated value of $1.72 billion in 2025, the market reflects sustained demand driven by both acute-care needs and the expanding homecare respiratory segment.

• •Market valued at approximately $1.72 billion in 2025 with a 6.32% projected CAGR through 2030-2033
• •Strong reimbursement framework under France's universal healthcare system supports broad patient access
• •Homecare respiratory care is an expanding segment alongside traditional hospital-based equipment

France's aging demographic profile is a primary driver, as respiratory diseases such as chronic obstructive pulmonary disease (COPD), interstitial lung disease, and obstructive sleep apnea (OSA) increase significantly with age. Rising obesity rates have contributed to higher OSA prevalence, expanding the addressable market for CPAP and APAP devices. Additionally, the COVID-19 pandemic elevated public and clinical awareness of respiratory health, accelerating investment in respiratory care infrastructure, remote monitoring, and home-based treatment options.

• •Aging population and associated rise in COPD, asthma, and sleep-disordered breathing diagnoses
• •Obesity epidemic driving growth in obstructive sleep apnea and positive airway pressure device demand
• •Post-pandemic prioritization of respiratory preparedness and homecare ventilation adoption

The market is segmented by product type into positive airway pressure devices, ventilators, oxygen therapy systems, nebulizers, humidifiers, and airway management devices. Île-de-France, encompassing Paris and its surrounding metropolitan area, commands the largest regional share due to high population density, concentration of major hospital networks, and greater per-capita healthcare spending. Other significant regional markets include Auvergne-Rhône-Alpes and Provence-Alpes-Côte d'Azur, which have above-average elderly populations and established pulmonology care centers.

• •Positive airway pressure devices and oxygen therapy systems represent the largest product segments
• •Île-de-France leads regional demand due to dense hospital infrastructure and population concentration
• •Southern and eastern regions show above-average demand correlated with older demographic profiles

What are the recent trends and outlook?

The market is moving toward portable and wearable respiratory devices, with manufacturers investing in miniaturized ventilators and lightweight oxygen concentrators suitable for ambulatory patients. Digital health integration, including connected devices, telemedicine platforms, and remote patient monitoring, is accelerating as providers and payers seek to reduce hospital readmissions and improve chronic disease management. The long-term outlook through 2033 remains positive, with continued product innovation, favorable demographics, and sustained healthcare expenditure supporting steady market expansion.

• •Portable and home-use respiratory devices are outpacing traditional hospital equipment in growth rate
• •Connected respiratory devices with remote monitoring and telehealth integration are gaining clinical adoption
• •Market outlook through 2033 remains strong, supported by demographic trends, R&D investment, and homecare expansion